We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Communication Bridge Speech Therapy Research Study

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02439853
First Posted: May 12, 2015
Last Update Posted: November 17, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Alzheimer's Association
The Association for Frontotemporal Degeneration
Illinois Department of Public Health
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Emily Rogalski, Northwestern University
April 23, 2015
May 12, 2015
November 17, 2017
March 2013
December 2019   (Final data collection date for primary outcome measure)
Assessment of Functional Communication Abilities [ Time Frame: Change from baseline assessment at 2-months, 6-months and 12-months post-treatment ]
Functional Communication Abilities will be assessed through questionnaires about the participant's language and communication, neuropsychological testing, and speech and language therapy evaluations.
Same as current
Complete list of historical versions of study NCT02439853 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Communication Bridge Speech Therapy Research Study
Communication Bridge Speech Therapy Research Study: Using Internet-Based Speech Therapy to Improve Quality of Life and Access to Care
This is a study on Internet-based video-practice speech and language therapy for persons with primary progressive aphasia (PPA), behavioral-variant frontotemporal dementia (bvFTD), or related conditions.

The purpose of this study is:

  1. To evaluate the effectiveness of speech and language therapy on a person's ability to communicate immediately after treatment, 6-months after treatment, and 12-months after treatment.
  2. To identify the most effective speech and language therapy strategies for persons with these conditions.
  3. To determine the feasibility of Internet-based video-practice of speech and language therapy for persons with these conditions.

The study will involve 12 to 15 session over the course of 12 months. Some of these sessions will be in-person at the Northwestern Cognitive Neurology and Alzheimer's Disease Center (Chicago, IL), while others will take place over the Internet, using an online study portal.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
  • Primary Progressive Aphasia
  • Frontotemporal Dementia
Behavioral: Monthly Check-in Session
Subjects in the Check-In group will have an online session with a speech-language pathologist 3-, 4-, and 5-months from the subject's enrollment date.
  • Experimental: Check-In group
    Subjects in the Check-In group will undergo three check-in sessions with the speech therapist. These sessions will happen remotely, via video-chat, and will last less than an hour. They will occur at 3-, 4-, and 5-months from the subject's enrollment date.
    Intervention: Behavioral: Monthly Check-in Session
  • No Intervention: Control Arm
    Subjects in the Control arm will not undergo three check-in sessions with the speech therapist.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
57
January 2021
December 2019   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of dementia with language as a primary symptom (i.e. aphasia)
  • An informant who knows the participant well and can answer questions the participant's communication ability
  • Adequate hearing to follow conversation (correction permitted)
  • Adequate vision (correction permitted)
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT02439853
STU00073634
No
Not Provided
Not Provided
Emily Rogalski, Northwestern University
Northwestern University
  • Alzheimer's Association
  • The Association for Frontotemporal Degeneration
  • Illinois Department of Public Health
  • National Institutes of Health (NIH)
Principal Investigator: Emily J Rogalski, PhD Northwestern University
Northwestern University
November 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP